Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.

BACKGROUND Microsomal epoxide hydrolase 1 (EPHX1) may play an important role in epigenetic change and DNA repair concerned with lung cancer. Several studies have investigated the association between EPHX1 rs1051740 and lung cancer risk, but there is no consensus. Therefore, we performed a meta-analysis to further identify the relationship. METHODS The Pubmed and Embase databases were searched for eligible studies. An odds ratio (OR) with 95% confidence intervals (CIs) was used to assess the correlation between EPHX1 rs1051740 polymorphism and lung cancer risk through a meta-analysis. RESULTS Overall, no significant relationship was found between EPHX1 rs1051740 and lung cancer risk (CC vs. TT: OR=1.10, 95% CI=0.88-1.36; CC+CT vs. TT: OR=1.02, 95% CI=0.88-1.18; CC vs. TT+CT: OR=1.08, 95% CI=0.91-1.27; C vs. T: OR=1.04, 95% CI=0.93-1.17; CT vs. TT: OR=0.98, 95% CI=0.85-1.13). Nevertheless, further subgroup analysis by ethnicity demonstrated that EPHX1 rs1051740 with CC genotype or C allele was an increased risk for lung cancer in Asians (CC vs. TT: OR=1.54, 95% CI=1.23-1.94; CC vs. TT+CT: OR=1.43, 95% CI=1.20-1.71; C vs. T: OR=1.26, 95% CI=1.08-1.47). CONCLUSIONS This meta-analysis indicates that EPHX1 rs1051740 with CC genotype or C allele may be a risk factor in Asians.

[1]  L. Voltolini,et al.  Prognostic Nomogram to Predict Survival After Surgery for Synchronous Multiple Lung Cancers in Multiple Lobes , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  S. Fu,et al.  Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials , 2015, Current medical research and opinion.

[3]  L. Wilson,et al.  Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Shadil Ibrahim Wani,et al.  Trigger factor assisted folding of the recombinant epoxide hydrolases identified from C. pelagibacter and S. nassauensis. , 2014, Protein expression and purification.

[5]  J. Gui,et al.  Role of a Genetic Variant on the 15q25.1 Lung Cancer Susceptibility Locus in Smoking-Associated Nasopharyngeal Carcinoma , 2014, PloS one.

[6]  P. Chanvorachote,et al.  Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells , 2014, PloS one.

[7]  B. Melosky Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer , 2014, Front. Oncol..

[8]  Vincenzo Lagani,et al.  Hidden Treasures in “Ancient” Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue , 2014, Front. Oncol..

[9]  Guiping Wang,et al.  Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects , 2014, Journal of experimental & clinical cancer research : CR.

[10]  L. Xian,et al.  Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer. , 2014, Genetics and molecular research : GMR.

[11]  S. Oh,et al.  The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer , 2014, Radiation oncology journal.

[12]  Jie Fu,et al.  Simvastatin inhibits the proliferation of A549 lung cancer cells through oxidative stress and up-regulation of SOD2. , 2014, Die Pharmazie.

[13]  M. White,et al.  The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study , 2014, British Journal of Cancer.

[14]  Z. Zhang,et al.  High TBX2 expression predicts poor prognosis in non-small cell lung cancer. , 2014, Neoplasma.

[15]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[16]  M. Gonsebatt,et al.  Genetic Susceptibility to Lung Cancer Based on Candidate Genes in a Sample from the Mexican Mestizo Population: A Case–Control Study , 2014, Lung.

[17]  M. Fathy,et al.  Association Between Environmental Tobacco Smoke Exposure and Lung Cancer Susceptibility: Modification by Antioxidant Enzyme Genetic Polymorphisms , 2013, Molecular Diagnosis & Therapy.

[18]  Y. Kakeji,et al.  Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: The Fukuoka Colorectal Cancer Study , 2013, Molecular carcinogenesis.

[19]  L. Hou,et al.  Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene‐exposed workers , 2013, Environmental and molecular mutagenesis.

[20]  Siwen Wang,et al.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer , 2013, Tumor Biology.

[21]  Ding Yuan,et al.  Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and Colorectal Cancer Risk , 2012, PloS one.

[22]  Tariq Ahmad Masoodi,et al.  Functional genomics based prioritization of potential nsSNPs in EPHX1, GSTT1, GSTM1 and GSTP1 genes for breast cancer susceptibility studies. , 2012, Genomics.

[23]  C. Cacına,et al.  Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society. , 2012, Genetic testing and molecular biomarkers.

[24]  Leah E. Mechanic,et al.  EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[25]  Zhe Zhang,et al.  Low microsomal epoxide hydrolase expression is associated with bladder carcinogenesis and recurrence. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[26]  D. Dobrota,et al.  Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population. , 2012, Neoplasma.

[27]  B. Mittal,et al.  Association of Functionally Important Polymorphism of Microsomal Epoxide Hydrolase Gene (EPHX1) With Lung Cancer Susceptibility , 2011, Cancer investigation.

[28]  B. Ring,et al.  Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis , 2011, PloS one.

[29]  T. Isbir,et al.  Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. , 2010, Tumori.

[30]  M. Arand,et al.  Mammalian epoxide hydrolases in xenobiotic metabolism and signalling , 2009, Archives of Toxicology.

[31]  John D Potter,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[32]  D. Srivastava,et al.  Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India , 2008, Archives of Toxicology.

[33]  R. D. Mittal,et al.  Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. , 2007, DNA and cell biology.

[34]  William S. Beckett,et al.  Asbestos-related lung disease. , 2007, American family physician.

[35]  F. Oesch,et al.  Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.